Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes
Authors:
- Wolfgang StuderWSWolfgang Studer
- Verena FigueiredoVFVerena Figueiredo
- Andreas J. BircherABAndreas J. Bircher
- 1 March 2006
- journal article
- case report
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 96 (3) , 497-500
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Flow‐assisted diagnosis of anaphylaxis to patent blueAllergy, 2005
- Recent Development of Sentinel Lymph Node Biopsy for Breast Cancer in JapanAsian Journal of Surgery, 2004
- Efficacy of Methylene Blue Dye in Localization of Sentinel Lymph Node in Breast Cancer PatientsThe Breast Journal, 2004
- Clinical features and severity grading of anaphylaxisJournal of Allergy and Clinical Immunology, 2004
- Near-fatal anaphylaxis to patent blue VBritish Journal of Dermatology, 2004
- Anaphylactoid Reactions to Isosulfan Blue Dye During Breast Cancer Lymphatic Mapping in Patients Given Preoperative ProphylaxisJournal of Clinical Oncology, 2004
- Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast CancerAnesthesia & Analgesia, 2002
- Anaphylaxis to isosulfan blueAnnals of Allergy, Asthma & Immunology, 2002
- Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedureJournal of Surgical Oncology, 1999
- Anapylaxis to Patent BlueDermatology, 1998